| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/13/2005 | CN1638819A Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 07/13/2005 | CN1638801A Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638797A Cancer treatment |
| 07/13/2005 | CN1638793A Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638789A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 07/13/2005 | CN1638779A Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 07/13/2005 | CN1638775A Nitric oxide donors for treatment of disease and injury |
| 07/13/2005 | CN1638772A Anti-viral compounds |
| 07/13/2005 | CN1638770A Composition and potentiating method |
| 07/13/2005 | CN1638767A Combinations comprising epothilone derivatives and alkylating agent |
| 07/13/2005 | CN1638766A Use of substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase |
| 07/13/2005 | CN1638764A Eye drops containing tetrazole derivative |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/13/2005 | CN1638759A Pharmaceutical composition comprising a bisphosphonate and a COX-2 inhibitor for the treatment of bone diseases |
| 07/13/2005 | CN1638758A Stimulation of CPT-1 as a means to reduce weight |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1638755A Body temperature elevating agents |
| 07/13/2005 | CN1638753A Potentiation of therapeutic effects of fatty acids |
| 07/13/2005 | CN1638751A Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers CRP and SAA |
| 07/13/2005 | CN1638749A Ambroxol for treating painful conditions in the mouth and pharyngeal cavity |
| 07/13/2005 | CN1638739A Compound for treating assuetude disturbance |
| 07/13/2005 | CN1638735A Cubic liquid crystalline compositions and methods for their preparation |
| 07/13/2005 | CN1638732A Sustained release drug formulations containing a carrier peptide |
| 07/13/2005 | CN1638731A Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
| 07/13/2005 | CN1638730A Formoterol superfine formulation |
| 07/13/2005 | CN1638729A Pressurised metered dose inhalers containing solutions of beta-2 agonists |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1637416A Fp-ghrelin |
| 07/13/2005 | CN1637149A Novel use |
| 07/13/2005 | CN1637018A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636990A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/13/2005 | CN1636599A Medicine composition and kit for local narcosis or relieving pain |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
| 07/13/2005 | CN1636590A Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 07/13/2005 | CN1636577A Vaginal care composition |
| 07/13/2005 | CN1636566A Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 07/13/2005 | CN1636561A Use of at-1 receptor antagonist for treating diseases associated with an increase of at-1 receptors |
| 07/13/2005 | CN1636553A Volatile proof solid preparation and producing method thereof |
| 07/13/2005 | CN1636552A Ascending-dose dosage form |
| 07/13/2005 | CN1636546A Sprayable skin protectant compositions |
| 07/13/2005 | CN1636453A Use of naphtoquinone compounds for the preparation of biocidal compositions and derivative composition |
| 07/13/2005 | CN1210275C Respiratory syncytial virus replication inhibitors |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210261C Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |
| 07/13/2005 | CN1210258C Glyburide composition |
| 07/13/2005 | CN1210064C Compositions for the treatment of coccidiosis |
| 07/13/2005 | CN1210063C Complex local medicine for mainly treating oral ulcer |
| 07/13/2005 | CN1210037C Glucosamine and egg for reducing inflammation |
| 07/13/2005 | CN1210030C Antimicrobial composition and method for producing same |
| 07/13/2005 | CN1210027C Pharmaceutical compositions for ulcer and application thereof |
| 07/13/2005 | CN1210020C Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma |
| 07/12/2005 | US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916859 Anti-microbial tool grip |
| 07/12/2005 | US6916852 Vasoconstriction of arteries by administering to opiate receptor agonist and cyclooxygenase inhibitor; prophylaxis of hypotension |
| 07/12/2005 | US6916843 Prevention cell damage due oxygen toxicity by administering epoxyeicosatrienoic acids and/or metabolites, from cytochrome-P450 monooxygenase enzyme ststem |
| 07/12/2005 | US6916823 Method of treatment of dopamine-related dysfunction |
| 07/12/2005 | US6916811 Adenosine A2a receptor antagonists |
| 07/12/2005 | US6916810 αν integrin receptor antagonists |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916800 Gelatinase inhibitors; anticancer agents |
| 07/12/2005 | US6916794 Method of enhancing drainage of lacrimal system with purinergic receptor agonists |
| 07/12/2005 | US6916629 Tissue factor pathway inhibitor-3 |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation |
| 07/12/2005 | US6916494 Ointment formed of natural substances including those of the genera Glycyrrhizae Radix, Testudinis Carapax, Cervi Parvum Cornu, Rhei Rhizoma, Ephedrae Herba, Natrii Sulfas, Moutan Radicis Cortx, Menthae Herba in aqueous medium |
| 07/12/2005 | US6916476 Keyhole limpet hemocyanin (klh); anticancer agents; treating melanoma |
| 07/12/2005 | CA2349142C Compositions and methods for stimulating gastrointestinal motility |
| 07/12/2005 | CA2303309C Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 07/12/2005 | CA2160798C Gaba-ergic modulation of eye growth |
| 07/07/2005 | WO2005061725A1 Methods for detecting markers associated with endometrial disease or phase |
| 07/07/2005 | WO2005061684A1 Fat composition |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005061000A1 Remedy for angitis |
| 07/07/2005 | WO2005060980A1 Drug for treating disease and drug for treating diabetes |
| 07/07/2005 | WO2005060978A2 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies |
| 07/07/2005 | WO2005060976A2 Use of superoxide dismutase mimetics and reductase glutathione in the form of anticancer drugs |
| 07/07/2005 | WO2005060975A1 Combination therapies employing a composition comprising a hmg coa reductase inhibitor and a vitamin b6 related compound |
| 07/07/2005 | WO2005060968A1 Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 07/07/2005 | WO2005060967A1 METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS |
| 07/07/2005 | WO2005060966A1 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist |
| 07/07/2005 | WO2005060955A1 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and an agent intervening in the prostaglandin metabolism |
| 07/07/2005 | WO2005060951A2 Anti-neoplastic agents, combination therapies and related methods |
| 07/07/2005 | WO2005060946A1 Continuous combination therapy with selective prostaglandin ep4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass |
| 07/07/2005 | WO2005060709A2 Methods of use of probiotic bifidobacteria for companion animals |
| 07/07/2005 | WO2005060708A2 Canine probiotic lactobacilli |
| 07/07/2005 | WO2005041960A3 Neuromuscular blocking agents and antagonists thereof |
| 07/07/2005 | WO2005027663A3 Compositions comprising oligosaccharides |
| 07/07/2005 | WO2005023304A3 Antimalarial compositions and manufacturing process thereof |
| 07/07/2005 | WO2005017095A3 A stable liquid probiotic composition, preparation and applications thereof |
| 07/07/2005 | WO2005016265A3 Method for promoting bone growth |
| 07/07/2005 | WO2005016114A3 Generation of living tissue constructs in vivo using a mold |
| 07/07/2005 | WO2005014776A3 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |